China Pharmaceuticals and Healthcare Report - Q4 2014

Business Monitor International
September 10, 2014
197 Pages - SKU: BMI5325553
Countries covered: China

China Pharmaceuticals and Healthcare Report - Q4 2014

BMI View: A more 'rational' use of pharmaceuticals through pharmacoeconomics, and a crackdown onillegal rebates and corruption in China's pharmaceutical market could hinder the sector's growth potential.

However, over the long term, the government is likely to improve its investment in healthcare in order toretain public support.

Headline Expenditure Projections

Pharmaceuticals: CNY532.4bn (US$86.6bn) in 2013 to CNY616.1bn (US$99.3bn) in 2014; +15.7% inlocal currency and +14.7% in US dollar terms. Forecast broadly unchanged from Q313.

Healthcare: CNY3,230.8bn (US$525.4bn) in 2013 to CNY3,692.0bn (US$595.2bn) in 2014; +14.3% inlocal currency terms and +13.3% in US dollar terms. Forecast remains unchanged from Q313.



More Prescription Drugs reports by Business Monitor International

Japan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Japan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Japanese pharmaceutical market continues to hold strong rewards for innovativepharmaceutical companies. This is driven by the ...
Tanzania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Tanzania Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect the continuing depreciation of the Tanzanian shilling to make imports of rawmaterials increasingly expensive for ...
Romania Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Romania Pharmaceuticals and Healthcare Report Q1 2015BMI View: Romania's claw back tax is likely to see a revision as domestic companies lobby to push theburden ...
Latvia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Latvia Pharmaceuticals and Healthcare Report Q1 2015BMI View: Market growth forecasts are strong although the country will continue to present a modestopportunity to larger multinational ...
See all reports like this >>

More China Prescription Drugs reports

Pharmaceuticals in China: ISIC 2423 by Euromonitor International
Pharmaceuticals in China: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
Pediatric Drugs Markets in China by Asia Market Information & Development Company
Pediatric Drugs Markets in ChinaChina's demand for Pediatric Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
Antibiotics Markets in China by Asia Market Information & Development Company
Antibiotics Markets in ChinaChina's demand for Antibiotics has grown at a fast pace in the past decade. In the next decade, both production and demand ...
Prescription Drugs Markets in China by Asia Market Information & Development Company
Prescription Drugs Markets in ChinaChina's demand for Prescription Drugs has grown at a fast pace in the past decade. In the next decade, both production ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!